Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

UGRP1 Inhibitors

GRP1 inhibitors belong to a distinct chemical class characterized by their ability to selectively target and modulate the activity of the Upstream Gene Regulatory Protein 1 (UGRP1). UGRP1 is a crucial element in cellular processes, particularly in the regulation of gene expression. This class of inhibitors is designed to interfere with the function of UGRP1, ultimately influencing downstream molecular events. Structurally, UGRP1 inhibitors exhibit diverse chemical compositions, often featuring specific motifs or functional groups essential for binding to the active site of UGRP1. Through this interaction, these inhibitors can disrupt the normal functioning of UGRP1, leading to altered gene expression patterns within the cell.

UGRP1 inhibitors involves their ability to competitively bind to the active site of UGRP1, thereby impeding its normal interaction with cellular components involved in gene regulation. This interference can result in a cascade of molecular events, influencing the transcriptional and translational processes controlled by UGRP1. Researchers and medicinal chemists continually explore and optimize the chemical structures of UGRP1 inhibitors to enhance their potency, selectivity, and pharmacokinetic properties. Understanding the intricate details of the interaction between UGRP1 and its inhibitors provides valuable insights for designing novel compounds with improved efficacy and reduced off-target effects. This ongoing research contributes to the advancement of our knowledge in the field of molecular biology and may hold potential implications for various biological studies.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

Glucocorticoid that can suppress inflammation, potentially downregulating SCGB3A2 expression related to inflammatory responses.

Aspirin

50-78-2sc-202471
sc-202471A
5 g
50 g
$20.00
$42.00
4
(1)

Nonsteroidal anti-inflammatory drug that may reduce the expression of SCGB3A2 by modulating the inflammatory process.

Ibuprofen

15687-27-1sc-200534
sc-200534A
1 g
5 g
$53.00
$88.00
6
(0)

NSAID that may alter SCGB3A2 levels indirectly through its anti-inflammatory effects.

Zileuton

111406-87-2sc-204417
sc-204417A
sc-204417B
sc-204417C
10 mg
50 mg
1 g
75 g
$84.00
$307.00
$369.00
$1254.00
8
(1)

5-lipoxygenase inhibitor that could influence SCGB3A2 expression by altering leukotriene synthesis, involved in inflammation.

Budesonide

51333-22-3sc-202980
sc-202980A
sc-202980B
sc-202980C
50 mg
100 mg
200 mg
500 mg
$79.00
$90.00
$154.00
$350.00
3
(1)

Corticosteroid that may impact the level of SCGB3A2 by modulating the immune response in the airways.

Prednisolone

50-24-8sc-205815
sc-205815A
1 g
5 g
$84.00
$253.00
2
(1)

Synthetic corticosteroid that can influence SCGB3A2 expression as part of its anti-inflammatory action.

Theophylline

58-55-9sc-202835
sc-202835A
sc-202835B
5 g
25 g
100 g
$20.00
$32.00
$85.00
6
(0)

Methylxanthine drug that can affect SCGB3A2 through its bronchodilator and anti-inflammatory effects.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$94.00
$213.00
33
(5)

Antimetabolite and anti-inflammatory agent that may affect SCGB3A2 expression indirectly by modulating immune system activity.

Hydrocortisone

50-23-7sc-300810
5 g
$102.00
6
(1)

Corticosteroid that can influence SCGB3A2 activity through its anti-inflammatory properties.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Bioactive compound from turmeric that may modulate SCGB3A2 by its anti-inflammatory and antioxidant actions.